Atlas Trials

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Clinical trial NCT00811889 · COMPLETED

Trial details

NCT number
NCT00811889
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney DiseaseType 2 DiabetesDiabetic Nephropathy
Start date
2009-04-30
Primary completion
2010-05-31
Enrollment
227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.